Skip to content Skip to main navigation Report an accessibility issue

Dear Colleague

To sign up for the digest, click here.

Federal Opportunities

Please contact Paul Montgomery (paul.montgomery@utk.edu) regarding your interest in federal opportunities.

DoD recently published the attached solicitation entitled Defense Enterprise Science Initiative. DESI is a new program that supports use-inspired basic research performed by university-industry teams in order to accelerate the impact of knowledge on key defense challenges and on DoD acquisition programs.

DESI is seeking proposals on the following 4 specific topics:

  • Power Beaming
  • Hihly-maneuverable autonomous UAV
  • Soft Active Composites with Intrinsic Sensing, Actuation, and Control
  • Metamaterial-based Antennas

The proposal deadline is 28 Feb 2018.  DoD anticipates making 4 awards of $750K annually for a period of 2 years, with an option for a third year of additional funding.  Note that each proposal must include at least 1 university and 1 industry member, and the university partner must receive at least 50% of requested funding.  Also note that not every topic above will necessarily be granted an award.

NIH Opportunities

Join the UT NIH Research Community by contacting Jennifer Webster (jwebster@utk.edu) and start receiving the weekly NIH Digest.

  • NIH Standard Deadlinesfor Investigator-Initiated Research Projects
  • NIH BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 – Clinical Trials Optional)(RFA-NS-18-018)
  • NIH BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44 Clinical Trial Not Allowed)(PAR-18-501)
  • NIH BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR)(R41/R42 Clinical Trial Not Allowed)(PAR-18-515)
  • NIH BRAIN Initiative: Targeted BRAIN Circuits Planning Projects Targeted BCPP (R34 – Clinical Trials Not Allowed)(RFA-NS-18-014)
  • NIH Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)(PA-18-504)
  • NIH Advancing the Science of Geriatric Palliative Care (R01 – Clinical Trial Optional)(PA-18-502)
  • NIH Advancing the Science of Geriatric Palliative Care (R21 – Clinical Trial Optional)(PA-18-503)
  • NCCIH Discovery and Biological Signatures of Diet Derived Microbial Metabolites (R01 Clinical Trial Optional)(RFA-AT-18-003)
  • NCI Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet)(Admin Suppl – Clinical Trial Not Allowed)(PA-18-496)
  • NCI Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)(PA-18-492)
  • NCI Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)(PA-18-493)
  • NHLBI Deciphering the Molecular Landscape of Lung Aging in Humans (U01 – Clinical Trial Not Allowed)(RFA-HL-19-012)
  • NIA From Association to Function in the Alzheimer’s Disease Post-Genomics Era (R01 – Clinical Trial Not Allowed)(RFA-AG-18-026)
  • NIA Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer’s Disease (R01 – Clinical Trial Not Allowed)(RFA-AG-18-027)
  • NIA Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimer’s Disease Risk (R01 – Clinical Trial Not Allowed)(RFA-AG-18-029)
  • NIA Pragmatic Trials of Managing Multimorbidity in Alzheimer’s Disease (R01 Clinical Trial Required)(RFA-AG-18-028)
  • NIA Sleep disorders and circadian clock disruption in Alzheimer’s disease and other dementias of aging (R01 Clinical Trial Not Allowed)(PAR-18-497)
  • NIAAA Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity Limited Competition (U01 Clinical Trial Not Allowed)(RFA-AA-18-008)
  • NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional)(PAR-18-433)
  • NIBIB Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)(PAR-18-434)
  • NIDCD Early Career Research(ECR) Award (R21 – Clinical Trials Optional)(PAR-18-487)
  • NICHD Non-Invasive Diagnostics to Improve Gynecologic Health (R43/R44 – Clinical Trial Optional)(RFA-HD-19-006)
  • NICHD Studies in Neonatal and Pediatric Resuscitation (R01 Clinical Trial Optional)(PA-18-485)
  • NICHD Studies in Neonatal and Pediatric Resuscitation (R03 – Clinical Trial Optional)(PA-18-491)
  • NIDA Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)(RFA-DA-19-002)
  • NIDA Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional)(PAR-18-494)
  • NIDCR Dental Specialty and PhD Program (DSPP)(K12-Clinical Trials Not Allowed)(RFA-DE-18-012)
  • NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required)(PAR-18-432)
  • NIDDK Academic Research Enhancement Award in Diseases within the Mission of NIDDK (R15 – Clinical Trial Required)(PA-18-495)
  • NIDDK / NCATS Microphysiological Systems (MPS) for Modeling Diabetes (UG3/UH3 Clinical Trial Not Allowed)(RFA-DK-17-035)
  • NEI Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional)(PA-18-500)
  • NINR End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional)(PA-18-498)
  • NINR End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional)(PA-18-499)

NSF Opportunities

Please contact Sharon Pound (spound@utk.edu) regarding your interest in NSF opportunities.

  • Critical Resilient Interdependent Infrastructure Systems and Processes 2.0 FY18 (CRISP 2.0) NSF 18-523

Dear Colleague Letters

  • ENG/CMMI Call for NSF Big Ideas Proposals NSF 18-029 Dec. 4, 2017
  • Delay in Issuance of Revised Program Solicitations for CEDAR, GEM, and SHINE  NSF 18-030 Dec. 8, 2017
  • Rules of Life (RoL): Forecasting and Emergence in Living Systems (FELS) NSF 18-031 Dec. 11, 2017
  • RAISE on Enabling Quantum Leap: Transformational Advances in Quantum Systems NSF 18-035 Dec. 14, 2017

here to sign up for the Limited Submissions mailing list to receive funding opportunity announcements.

Contact Hannah Schmidt (hschmidt@utk.edu) if you have any questions.

NIH Opportunities

Join the UT NIH Research Community by contacting Jennifer Webster (jwebster@utk.edu) and start receiving the weekly NIH Digest.

  • NIH Standard Deadlines for Investigator-Initiated Research Projects
  • NIH Academic Research Enhancement Award (R15 Clinical Trial Required) (PA-18-343)
  • NIH Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional) (PA-18-284)
  • NIH Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional) (PA-18-285)
  • NIH Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) (PA-18-001)
  • NIH Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Optional) (PAR-18-112)

Continue reading →

here.

Applicants may be a doctoral candidate, an early career researcher, or an established researcher. This is not a limited submission; anyone who is qualified is welcome to apply. The application deadline is November 1. If you have any questions about this opportunity or would like assistance developing your proposal, please contact the Faculty Development Team at fdt@utk.edu.

Limited Submission Opportunities

Find information about limited submissions on the Limited Submissions Opportunities page.

DOE: Consolidated Innovative Nuclear Research – Nuclear Energy Enabling Technologies (NEET)

The Department of Energy’s (DOE) Office of Nuclear Energy (NE) conducts crosscutting nuclear energy research and development (R&D) and associated infrastructure support activities to develop innovative technologies that offer the promise of dramatically improved performance for advanced reactors and fuel cycle concepts while maximizing the impact of DOE resources.

They are currently accepting proposals for the following workscopes:

  • Advanced Methods for Manufacturing (NEET-1)
  • Advanced Digital Monitoring and Control Technology (NEET-2)

Please see the full opportunity description for complete information.

DEADLINES:
Notification of Interest to ORE: 10/30/2017 12 NOON
Application to Agency: 1/23/2018
Limit on Number of Applications: 3
Estimated Program Funding: Up to $1 million per award
Anticipated No. of Awards: 7

Continue reading →

Limited Submissions Opportunities page.

The Tennessee Arts Commission is providing funds for diverse arts projects in urban (APS) and rural (RAPS) counties. Proposed arts projects must involve one or more Commission recognized art forms, including: visual arts, craft, media, design, music, theater, dance, folk and ethnic, or literary arts. A project may start no earlier than July 1, 2018, and must end no later than June 15, 2019.

Funding will depend upon an organization’s rating in the review process and upon the total amount of funds available to the Tennessee Arts Commission for grant allocation.

Please see the full opportunity description for complete information.

DEADLINES:
Notification of Interest to ORE: 10/16/2017 12 p.m.
Application to Agency: 1/22/2018
Limit on Number of Applications: 1
Estimated Program Funding: Up to $9k per award
Anticipated No. of Awards: TBD

Continue reading →

jwebster@utk.edu) and start receiving the weekly NIH Digest.

  • NIH Standard Deadlinesfor Investigator-Initiated Research Projects
  • NIH Roadmap Initiatives Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54) (RFA-RM-17-020)
  • NIH Roadmap Initiatives Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Research Program (U01) (RFA-RM-17-021)
  • NIH Roadmap Initiatives Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R01)(RFA-RM-17-022)
  • NIH Roadmap Initiatives Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (U01)(RFA-RM-17-023)
  • NIH Roadmap Initiatives Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R34)(RFA-RM-17-024)
  • NIH Roadmap Initiatives Science of Behavior Change: Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R21)(RFA-RM-17-028)
  • NIH BRAIN Initiative: Tools to Target, Identify, and Characterize Non-neuronal Cells in the Brain (R01 Clinical Trial Not Allowed) (RFA-DA-18-018)

Continue reading →

The flagship campus of the University of Tennessee System and partner in the Tennessee Transfer Pathway.